PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.\', \'Reference Center for Inherited Metabolic Diseases, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.\', \'INSERM, Paris, France.\', \'Imagine Institut des Maladies Génétiques, Paris, France and Department of Biotherapy, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.\', \'Faculté de Pharmacie, Université de Paris, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/10837450.2021.1871918
?:doi
?:hasPublicationType
?:journal
  • Pharmaceutical development and technology
is ?:pmid of
?:pmid
?:pmid
  • 33428504
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.479
?:rankingScore_hIndex
  • 48
?:title
  • Formulation and stability study of hydroxychloroquine sulfate oral suspensions.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33428504>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33428504>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all